Brettm Morrison News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nearly 70% of patients showed improvement after treatment with efgartigimod plus rHuPH20 in phase 2 of the largest randomized controlled trial for CIDP to date.

United statesJeffreya allenBrettm morrisonUniversity of minnesotaAmerican academy of neurologyJohns hopkins school of medicineAmerican academyPrimary endpointJohns hopkins schoolChronic inflammatory demyelinating polyradiculoneuropathyChronic inflammatory demyelinating polyneuropathyMmunoglobulin gImmunoglobulin aIntravenous immunoglobulinAdverse effectsSide effects